World Health Organization-backed COVAX is already working hard to deliver vaccines to lower-income countries, but earlier this year set up a new mechanism – called the COVAX Humanitarian Buffer – to deliver jabs to people in conflict zones or other settings that make access via healthcare systems almost impossible.
The buffer has been allocated 5% of all supplies of vaccines to COVAX, and J&J said it will start deliveries of its vaccine within the next few days.
The vaccines access group Gavi said earlier this year that the buffer will “act as a safety net for people that otherwise wouldn’t receive vaccines through other routes.”
